DE3485873D1 - Herpes simplex virus subunitimpfstoff. - Google Patents

Herpes simplex virus subunitimpfstoff.

Info

Publication number
DE3485873D1
DE3485873D1 DE8484110308T DE3485873T DE3485873D1 DE 3485873 D1 DE3485873 D1 DE 3485873D1 DE 8484110308 T DE8484110308 T DE 8484110308T DE 3485873 T DE3485873 T DE 3485873T DE 3485873 D1 DE3485873 D1 DE 3485873D1
Authority
DE
Germany
Prior art keywords
herpes simplex
simplex virus
type
subunitimpfstoff
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484110308T
Other languages
English (en)
Other versions
DE3485873T2 (de
Inventor
Yoichiro Kino
Nobuya Ohtomo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Publication of DE3485873D1 publication Critical patent/DE3485873D1/de
Application granted granted Critical
Publication of DE3485873T2 publication Critical patent/DE3485873T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
DE8484110308T 1983-08-31 1984-08-29 Herpes simplex virus subunitimpfstoff. Expired - Lifetime DE3485873T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58159641A JPS6051120A (ja) 1983-08-31 1983-08-31 単純ヘルペスサブユニットワクチン

Publications (2)

Publication Number Publication Date
DE3485873D1 true DE3485873D1 (en) 1992-09-24
DE3485873T2 DE3485873T2 (de) 1993-03-25

Family

ID=15698148

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484110308T Expired - Lifetime DE3485873T2 (de) 1983-08-31 1984-08-29 Herpes simplex virus subunitimpfstoff.

Country Status (9)

Country Link
US (1) US4661349A (de)
EP (1) EP0135841B1 (de)
JP (1) JPS6051120A (de)
KR (1) KR910005889B1 (de)
AT (1) ATE79548T1 (de)
AU (1) AU571569B2 (de)
CA (1) CA1244766A (de)
DE (1) DE3485873T2 (de)
SU (1) SU1554755A3 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244792A (en) * 1984-04-06 1993-09-14 Chiron Corporation Expression of recombinant glyoprotein B from herpes simplex virus
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
US4689225A (en) * 1984-11-02 1987-08-25 Institut Merieux Vaccine for cytomegalovirus
US4790987A (en) * 1985-11-15 1988-12-13 Research Corporation Viral glycoprotein subunit vaccine
CA1337395C (en) * 1986-10-20 1995-10-24 Rae Lyn Burke Recombinant herpes simplex gb-gd vaccine
US5149529A (en) * 1988-04-08 1992-09-22 Board Of Trustees Of Leland Chiron Corporation Compositions and treatment for herpes simplex
US5585264A (en) * 1988-07-15 1996-12-17 University Of Saskatchewan Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
US5081010A (en) * 1989-02-09 1992-01-14 Eastman Kodak Company Extraction composition, test kit and their use to extract or determine herpes simplex viral antigen
WO1990013652A1 (en) * 1989-05-12 1990-11-15 Triton Diagnostics, Inc. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
US6174916B1 (en) 1990-04-27 2001-01-16 Milkhaus Laboratory, Ltd. Methods for treating herpes virus infections
JP3005292B2 (ja) * 1990-08-02 2000-01-31 カイロン コーポレイション 単純ヘルペスウィルスのｖｐ１６のワクチン
US5334503A (en) * 1991-10-08 1994-08-02 Eastman Kodak Company Test kit and method for the detection of microorganisms associated with periodontal diseases using surfactant mixture as extraction composition
US5807557A (en) * 1994-07-25 1998-09-15 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex
US6156319A (en) * 1994-07-25 2000-12-05 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex vaccine
US6290967B1 (en) * 1996-12-20 2001-09-18 Merck & Co., Inc. Stabilizers for lyophilized vaccines
US6051385A (en) * 1997-10-22 2000-04-18 The Regents Of The University Of Michigan Compositions and methods for identifying and testing therapeutics against HSV infection
US20020090382A1 (en) * 2000-08-01 2002-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Antiviral compounds and methods
EP1494030B1 (de) * 2003-06-30 2013-11-27 Sysmex Corporation Lösung zur Vorbehandlung eines Grippevirentests basierend auf Immunchromatographie
WO2020113197A1 (en) * 2018-11-30 2020-06-04 Vaccine Stabilization Institute Viral formulations containing amino acids

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
IT1117218B (it) * 1979-05-18 1986-02-17 Depa Sas Procedimento per la produzione di un prodotto per la diagnosi dei tumori delle parti molli o carcinomi e prodotto ottenuto
US4341754A (en) * 1980-01-24 1982-07-27 Vanderbilt University Diagnostic reagent for herpes simplex virus encephalitis
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
US4430437A (en) * 1980-08-27 1984-02-07 The United States Of America As Represented By The Department Of Health And Human Services Test methods employing monoclonal antibodies against Herpes simplex virus types 1 and 2 nucleocapsids proteins
US4540669A (en) * 1980-09-11 1985-09-10 Merck & Co., Inc. Herpes simplex type I subunit vaccine
US4317811A (en) * 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
US4762708A (en) * 1982-02-18 1988-08-09 University Patents, Inc. Materials and methods for herpes simplex virus vaccination
US4535057A (en) * 1982-07-26 1985-08-13 Amf Incorporated Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
EP0133063B1 (de) * 1983-06-23 1987-01-07 Stanley Dr. Person Immunologisch reaktive nicht-glycosilierte Aminosäureketten von Glycoprotein-B des Herpes-Virus Typ 1 und Typ 2
US4533496A (en) * 1984-05-08 1985-08-06 Monsanto Company Method of isolating monoclonal antibodies from hybridoma cultures

Also Published As

Publication number Publication date
SU1554755A3 (ru) 1990-03-30
AU571569B2 (en) 1988-04-21
KR910005889B1 (ko) 1991-08-06
ATE79548T1 (de) 1992-09-15
AU3254184A (en) 1985-03-07
DE3485873T2 (de) 1993-03-25
JPS6051120A (ja) 1985-03-22
EP0135841B1 (de) 1992-08-19
US4661349A (en) 1987-04-28
EP0135841A2 (de) 1985-04-03
EP0135841A3 (en) 1986-05-28
KR850001700A (ko) 1985-04-01
CA1244766A (en) 1988-11-15

Similar Documents

Publication Publication Date Title
DE3485873D1 (en) Herpes simplex virus subunitimpfstoff.
PT80079A (en) Process for the preparation of antiviral pharmaceutical preparations containing 2-diethylamino-2,2',6'-acetoxyxylidide (lidocaine)
IE842210L (en) Vaccine
ZA826154B (en) Infectious bronchitis vaccines for poultry, process for the preparation of such vaccines, process for preventing infectious broachitis and infectious bronchitis virus strain
EP0203676A3 (en) Vaccine for generating an immunogenic t cell response protective against a virus
HK107595A (en) Recombinant herpes simplex gb-gd vaccine
AU6489986A (en) Thymidine kinase deletion mutants of bovine herpersvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same
ZA854832B (en) Potent thymopentin analogs
HK37397A (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
EP0079597A3 (en) Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
NZ203190A (en) Vaccines of infections bronchitis virus
AU6383296A (en) Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
IL88731A0 (en) Non-reverting rna viruses
AU7806187A (en) Sulphonamide derivatives for the treatment and prevention of viral diseases
HU9501426D0 (en) Microporous macrocapsules
AU554859B2 (en) Polymerized albumin vaccine
IE830861L (en) Equine influenza vaccine.
HUT44439A (en) Process for inhibiting the reproduction of viruses and virus infections
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same
WO1993014760A3 (en) Methods
EP0309898A3 (de) Methode zur Induktion einer zytotoxischen T-Zell-Antwort
EP0244760A3 (de) Impfstoff zur Verhütung von Marek-Krankheit
IE860983L (en) Antigens related to envelope glycoprotein of the virus of¹aids
GR960300005T1 (en) Extracts of piliostigma thonningii, the use thereof and formulations containing them.
NZ220611A (en) 30 residue influenza virus peptide, vaccines and antibodies

Legal Events

Date Code Title Description
8364 No opposition during term of opposition